Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 3766863)

Published in Am J Surg on October 01, 1986

Authors

P Scholl, R M Byers, J G Batsakis, P Wolf, H Santini

Associated clinical trials:

Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers | NCT04809324

Articles citing this

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol (2010) 1.81

Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions. J Clin Oncol (2015) 1.56

Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer (1996) 1.08

Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. Radiat Oncol (2014) 0.88

The impact of frozen sections on final surgical margins in squamous cell carcinoma of the oral cavity and lips: a retrospective analysis over an 11 years period. Head Neck Oncol (2011) 0.85

Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results. Strahlenther Onkol (2010) 0.82

Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control. JAMA Otolaryngol Head Neck Surg (2015) 0.82

Intraoperative consultation (IOC) in mucosal lesions of the upper aerodigestive tract. Head Neck Pathol (2008) 0.78

Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cell Mol Life Sci (2016) 0.77

The master switch: Comparative study of mast cell in oral epithelial dysplasia, oral submucous fibrosis and oral squamous cells carcinoma and their association with inflammation and angiogenesis. J Oral Maxillofac Pathol (2015) 0.77

Surgical errors and risks - the head and neck cancer patient. GMS Curr Top Otorhinolaryngol Head Neck Surg (2013) 0.76

Open questions and novel concepts in oral cancer surgery. Eur Arch Otorhinolaryngol (2015) 0.75

Articles by these authors

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med (1990) 3.69

The nature and significance of platelet products in human plasma. Br J Haematol (1967) 2.84

Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70

Sinonasal lymphomas. Ann Otol Rhinol Laryngol (1994) 2.56

Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell (1996) 2.32

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med (1996) 2.29

Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet (2000) 2.21

Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck (1997) 2.16

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med (1993) 2.10

Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry. Br J Dermatol (2011) 2.07

Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy. Int J Radiat Oncol Biol Phys (1990) 2.07

Polymorphous low-grade adenocarcinoma of minor salivary glands. A study of 14 cases of a distinctive neoplasm. Cancer (1984) 2.03

13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med (1986) 1.90

Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys (1993) 1.85

Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain (2012) 1.77

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75

Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology (2003) 1.70

Pathology consultation. Extracranial meningiomas. Ann Otol Rhinol Laryngol (1984) 1.65

Epithelial-myoepithelial carcinoma of intercalated duct origin. A clinicopathologic and ultrastructural assessment of sixteen cases. Oral Surg Oral Med Oral Pathol (1982) 1.60

Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions. Arch Pathol Lab Med (1984) 1.59

Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol (1984) 1.53

Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg (2000) 1.51

Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption. Br J Dermatol (2011) 1.50

Immunologic protection afforded by sunscreens beyond designated sun protection factors? J Invest Dermatol (1998) 1.48

Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol (1997) 1.47

Photopheresis for renal allograft rejection. Lancet (1995) 1.47

Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck (1992) 1.46

Synovial sarcomas of the head and neck. Ann Otol Rhinol Laryngol (1992) 1.45

The pathology of head and neck tumors: verrucous carcinoma, Part 15. Head Neck Surg (1983) 1.43

A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation. Anal Biochem (1983) 1.43

Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy. J Cardiovasc Electrophysiol (1996) 1.42

Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope (1995) 1.42

The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction. J Exp Med (1989) 1.41

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41

Mycobacterial disease of the head and neck: current perspective. Ann Otol Rhinol Laryngol (1995) 1.38

Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38

Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol (1997) 1.38

Acute encephalopathy with vigabatrin. Lancet (1993) 1.38

Invasive in vivo measurement of rear-, mid- and forefoot motion during walking. Gait Posture (2007) 1.37

Metastatic neoplasms to the head and neck. Surg Gynecol Obstet (1971) 1.35

The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature (1990) 1.34

Vascular compression of the duodenum. Emphasis on accurate diagnosis. Am J Surg (1968) 1.32

Proliferative verrucous leukoplakia and verrucous hyperplasia. Ann Otol Rhinol Laryngol (1994) 1.32

Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol (1983) 1.32

Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer (1995) 1.31

Salivary gland tumors in children. Ann Otol Rhinol Laryngol (1991) 1.30

Supraomohyoid neck dissection: rationale, indications, and surgical technique. Head Neck (1989) 1.29

Papillary squamous cell carcinomas of the upper aerodigestive tract: a clinicopathologic and molecular study. Head Neck (2000) 1.28

Foot kinematics during walking measured using bone and surface mounted markers. J Biomech (2007) 1.28

Basaloid squamous carcinoma of the upper aerodigestive tract. Clinicopathologic and DNA flow cytometric analysis. Cancer (1990) 1.28

Graded balloon dilation atrial septostomy as a bridge to lung transplantation in pulmonary hypertension. Am Heart J (1993) 1.27

Combined therapeutic approach to malignant lacrimal gland tumors. Am J Ophthalmol (1975) 1.26

Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene. Am J Clin Pathol (1995) 1.26

Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma (1997) 1.26

Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg (1995) 1.24

PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (1994) 1.23

The pathology of head and neck tumors: spindle cell lesions (sarcomatoid carcinomas, nodular fasciitis, and fibrosarcoma) of the aerodigestive tracts, Part 14. Head Neck Surg (1982) 1.23

The pathology of head and neck tumors: mucosal melanomas, part 13. Head Neck Surg (1982) 1.22

Salivary gland adenocarcinomas: a clinicopathologic analysis of three distinctive types. Semin Diagn Pathol (1987) 1.21

Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol (2000) 1.21

Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol (1985) 1.20

Hürthle cell lesions of the thyroid gland. Surg Gynecol Obstet (1974) 1.19

Targeted therapies for prostate cancer against the prostate specific membrane antigen. Curr Drug Targets (2009) 1.19

The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res (1977) 1.19

Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg (1991) 1.19

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst (1997) 1.19

Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg (1985) 1.18

The biological activity of d- and l-baclofen (Lioresal). Eur J Pharmacol (1978) 1.17

Spontaneous sharp waves in human neocortical slices excised from epileptic patients. Brain (1998) 1.17

The pathology of head and neck tumors: squamous and mucous-gland carcinomas of the nasal cavity, paranasal sinuses, and larynx, part 6. Head Neck Surg (1980) 1.16

An evaluation of the associations of leukemia and rubber industry solvent exposures. Am J Ind Med (1984) 1.16

Pathology consultation. Plasma cell tumors of the head and neck. Ann Otol Rhinol Laryngol (1983) 1.15

Histogenesis of salivary gland neoplasms. Otolaryngol Clin North Am (1977) 1.14

Treatment of stage I and II oral tongue cancer. Head Neck (1993) 1.13

The pathology of head and neck tumors: vasoformative tumors, part 9B. Head Neck Surg (1981) 1.13

Sinus aspergillosis and allergic fungal sinusitis. Ann Otol Rhinol Laryngol (1991) 1.12

Juvenile nasopharyngeal angiofibroma: an update of therapeutic management. Head Neck (1996) 1.12

Nasopharyngeal carcinomas in children. Arch Surg (1967) 1.12

Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg (1988) 1.12

Primary lymphomas and related benign lesions of the intestines. Am J Proctol (1966) 1.11

Undifferentiated carcinomas of the major salivary glands. Oral Surg Oral Med Oral Pathol (1990) 1.11

Central actions of histamine: microelectrophoretic studies. Brain Res (1977) 1.10

Pseudoparasitic (Liesegang) bodies in paranasal sinus. J Laryngol Otol (1988) 1.10

Evaluation of atpB nucleotide sequences for phylogenetic studies of ferns and other pteridophytes. Am J Bot (1997) 1.10

Sebaceous cell lesions of the head and neck. Arch Otolaryngol (1972) 1.10

Salivary gland neoplasia: an outcome of modified morphogenesis and cytodifferentiation. Oral Surg Oral Med Oral Pathol (1980) 1.09

The measurement of fibrinogen and its derivatives. I. Examination of methods of measurement of clottable fibrinogen. Med Lab Technol (1971) 1.09

Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol (1997) 1.08

Carcinomas ex monomorphic adenoma of salivary glands. J Laryngol Otol (1989) 1.08

Chondrosarcoma of the head and neck. Laryngoscope (1984) 1.07

Soft tissue tumors: unusual forms. Otolaryngol Clin North Am (1986) 1.07

Relation of photosensitivity to epileptic syndromes. J Neurol Neurosurg Psychiatry (1986) 1.07

Pseudolymphomas of the small intestine. Am J Gastroenterol (1965) 1.07

Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res (1995) 1.07

Anomalies of the first branchial cleft. Arch Otolaryngol (1976) 1.07

The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg (1978) 1.06

Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene (1999) 1.05